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Purpose
• To systematically review randomized controlled trial data to
compare the efficacy of uterine artery embolization (UAE), highintensity focused ultrasound (HIFU), hysterectomy, and medical
therapy in the management of symptomatic uterine fibroids

Methods
• Systematic review was performed of clinical literature to identify
Level I evidence that compares treatment modalities in the
management of symptomatic fibroids
• UAE, HIFU, hysterectomy, and medical therapy were assessed
• Five-year results from the REST trial and ten-year results from
the EMMY trial comparing clinical outcomes between
hysterectomy and UAE were evaluated1-2
• One network meta-analysis consisting of 47 randomized
controlled trials assessing the efficacy of medical therapy in the
management of uterine fibroids was evaluated3
• One randomized controlled trial comparing HIFU and UAE was
reviewed4
• Network meta-analysis could not be performed because each
study independently assessed different primary endpoints4

Results
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• The REST trial demonstrated that when comparing between
UAE and hysterectomy treatment groups at 5-years postprocedure, there was no difference when comparing quality
of life, complications, or adverse events1
• Higher need for re-intervention in the UAE group
(32%) versus the control group (4%)1
• The EMMY trial demonstrated that when comparing
between UAE and hysterectomy treatment groups at 10years post-procedure, that there was no difference between
quality of life, satisfaction, urogenital distress, or defecation
distress2
• 35% of the initial UAE group required hysterectomy
within 10-years post-procedure2
• The network meta-analysis demonstrates that no evidence
exists to support medical treatment to replace procedural
intervention3
• The randomized control trial and comprehensive cohort
analysis comparing HIFU and UAE at 6-weeks postprocedure illustrated no difference in symptom resolution,
incidence of adverse events, recovery time, or post-operative
opioid use4
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Conclusion

• Treatment modalities were assessed on the basis of symptom
relief, quality of life, need for re-treatment, the urogenital
distress inventory (UDI), the defecation distress inventory
(DDI), and recovery time1-4

• Endovascular therapy for symptomatic uterine fibroids with
UAE resulted in equivalent symptomatic relief, complications,
and risk for adverse events when compared with hysterectomy
and HIFU1-2
• UAE possesses a higher need for post-treatment reintervention1-2
• UAE is a fertility-preserving solution with shorter procedure
time and shorter post-procedural recovery1-2,4
• Insufficient long-term follow-up randomized controlled
evidence to currently support HIFU over UAE and
hysterectomy4
• No evidence to support medical intervention alone3
Figure 2 EMMY trial ten-year follow-up data for mental and physical health &
quality of life scored by Short Form (SF)-36; high mental and physical component
summaries indicate better functioning; high UDI and DDI scores indicate worse
functioning2
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